Call Us: 1.800.873.5297


Gynecologists Continue Using Power Morcellators Despite FDA Warning, The Wall Street Journal Reports

The Wall Street Journal reports that doctors nationwide are continuing to use a popular surgical tool, known as power morcellators, even after the United States Food and Drug Administration (FDA) warned that the device can spread undetected cancer. The Wall Street Journal notes that this demonstrates “the limits of the regulator’s reach into clinical practice.” In […]


FDA Issues Drug Safety Communication regarding Health Risks for Asthma Drug Xolair®

On September 26, the FDA issued a Drug Safety Communication regarding the health risks of the asmtha drug Xolair® (omalizumab). In particular, the FDA warned that a 5-year safety study suggests a slightly increased risk of cardiovascular and cerebrovascular serious adverse events (as a result of heart and brain blood vessel problems) for patients being […]


New Canadian Study Reveals Increased Risk of Permanent Nerve Damage with Use of Fluoroquinolones Antibiotics

The Vancouver Sun reports that an Ontario group of researchers at the University of British Columbia found a link between use of fluoroquinolones and peripheral neuropathy. In particular, the researchers found that men using these particular antibiotics, especially first-time users, were twice as likely to experience peripheral neuropathy as men who were not using fluoroquinolones. […]


Health Canada Warns of Cardiovascular Risks Associated with Testosterone Therapy Drugs

On July 15, 2014, Health Canada warned patients and healthcare professionals of serious and possibly life-threatening cardiovascular risks associated with testosterone replacement therapies. Health Canada recently completed a safety review of low-testosterone products, which revealed that Low-T product use is linked to heart and blood vessel problems, such as heart attack, stroke, pulmonary embolisms (blood […]


FDA Requires Revised Labeling for Testosterone Drugs to Warn of Increased Risk of Blood Clots

On June 20th, the U.S. Food and Drug Administration (FDA) issued a safety warning notifying health care professionals and medical care organizations that it will require manufacturers of approved testosterone products to revise their product labeling to include heightened warnings about the risk of venous blood clots. The previous labeling included the risk of blood […]


GlaxoSmithKline (GSK) Settles Promotion Claims: $105 Million Settlement

Bloomberg News reports that GlaxoSmithKline (GSK), the U.K.’s largest drug manufacturer, settled claims nationwide alleging the drug manufacturer illegally promoted asthma and antidepressant drugs. The company will contribute $105 million to a settlement fund over claims asserted by California, New York, and more than 40 other states. California will receive the bulk of the settlement […]


Doctor Admits Giving Patients the Wrong Radiation Doses

A Philadelphia doctor, who has been accused of botching dozens of prostate cancer surgeries at a Veterans Administration hospital, admitted Monday that he sometimes missed his target when implanting radioactive seeds, leaving patients with incorrect dosages.Dr. Gary Kao said these mistakes are commonplace when you are aiming seeds at the walnut-sized prostate, which sits near […]


Physicians Often Fail to Inform Patients of Abnormal Test Results

A study published in the Archives of Internal Medicine found that physicians frequently fail to report abnormal test results to patients. The study included 5,434 patients, ages 50 to 69, from 23 primary care practices in the Midwest and on the West Coast. Researchers looked at various tests such as cholesterol blood work, mammograms, Pap […]


Cancer Drug Erases Fingerprints

A Singapore man undergoing treatment was detained by U.S. immigration officials after the drug he was taking caused his fingerprints to disappear. The man, identified as Mr. S, was eventually allowed to enter the United States after officials determined he did not pose a threat to security. According to Mr. S’s oncologist, Eng-Huat Tan of […]

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.